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BACKGROUND: Emergency department (ED) visits towards the end-of-life by people with cancer 
are increasing over time. This is despite an association with poor patient and caregiver 
outcomes, most patients preferring home-based care, and capacity concerns for many EDs 
across developed countries. In order to develop appropriate interventions to reduce ED visits, a 
comprehensive understanding of cancer patients’ end-of-life ED use is vital.  
AIM: To understand variation in cancer patients’ end-of-life (last month) ED use in order to 
support the development of future initiatives aimed at reducing high attendance and improving 
equity of access to end-of-life healthcare services.  
DESIGN: A mixed methods study with a concurrent triangulation design. 
METHODS: Quantitative methods were used to describe cancer patients’ end-of-life ED use and 
investigate socio-demographic, clinical and environmental factors independently associated 
with multiple (≥2) ED visits towards the end-of-life. These comprised: secondary analysis of 
pooled data from two mortality follow-back studies: the QUALYCARE study (n=554) and the 
International Access, Rights and Empowerment (IARE) study (n=127); and, a population-based 
retrospective cohort study using linked patient-level data from the Office for National Statistics 
and Hospital Episode Statistics (n=124,030): dataset supplied by NHS Digital. Data was analysed 
using descriptive statistics, bivariate and multivariable logistic regression. A qualitative interview 
study explored advanced cancer patients’ and their caregivers’ decisions to seek ED care. Data 
was collected through semi-structured patient (n=18) and caregiver (n=6) interviews, and review 
of patients’ healthcare records. Interviews were audio recorded, transcribed verbatim and 
analysed using a constant comparative approach. Integration occurred at the study’s discussion 
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stage when findings from the quantitative and qualitative components were combined and 
overall conclusions made. 
RESULTS: Pooled data from the mortality follow-back studies comprised 681 cancer decedents 
(50.1% men; mean age at death 75 years). Of these, 29.7% experienced multiple ED visits during 
their last three months of life. Community health care services, in particular contact with 
palliative care, reduced the likelihood of patients experiencing aggressive end-of-life care, 
including multiple ED visits. The population-based retrospective cohort study identified 124,030 
adults who died from cancer in England during a one year period (01/04/11 to 31/03/12). Of 
these, 30.7% visited the ED once in their last month of life; 5.1% made multiple visits. Patients 
were more likely to visit the ED multiple times if they were: younger; male (adjusted odds ratio 
(AOR) 1.26, 95% confidence interval (CI) 1.19-1.34, reference female); Asian or Black (AOR 1.49, 
95% CI 1.27-1.74 and AOR 1.21, 95% CI 1.01-1.46 respectively, reference White); of lower socio-
economic status (AOR for most deprived quintile 1.19, 95% CI 1.09-1.30, reference least 
deprived quintile). Clinical characteristics associated with an increased odds of multiple ED visits 
were a higher co-morbidity score and diagnosis of lung or head and neck cancer (AOR 1.74, 95% 
CI 1.56-1.95 and AOR 1.67, 95% CI 1.40-2.00 respectively, reference colorectal cancer). Patients 
with a higher number of previous ED visits were found to have a greater odds of multiple ED 
visits in the last month of life; this followed a dose–response pattern (p for trend <0.001). In the 
qualitative data, four key issues influencing advanced cancer patients’ and their caregivers’ 
decisions to seek ED care emerged: 1. Disease-related anxiety – those with greater anxiety 
relating to their cancer diagnosis interpreted their symptoms as more severe and/or requiring 
immediate attention; 2. Prior patterns of health-seeking behaviour – at times of crisis 
participants defaulted to services they had previously used; 3. Feelings of safety and familiarity 
with the hospital setting – many felt reassured by the presence of healthcare professionals and 
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monitoring of their condition; and, 4. Difficulties accessing community healthcare services – 
especially urgently and/or out-of-hours. 
CONCLUSIONS: Socio-demographic (younger age; male sex; Asian or Black ethnicity; low socio-
economic status), clinical (high co-morbidity score; diagnosis of lung or head and neck cancer) 
and environmental (fewer community healthcare services; lack of palliative care; high previous 
ED use) factors are associated with an increased risk of multiple ED visits towards the end-of-life 
by people with cancer. Issues influencing advanced cancer patients’ and their caregivers’ 
decisions to seek ED care are complementary and propose underlying mechanisms of action for 
the quantitative associations found. Difficulties accessing community healthcare services and 
feelings of safety and familiarity with the hospital setting appear to support the quantitative 
environmental factors, whilst disease-related anxiety may explain some of the variation found 
in ED use across socio-demographic groups. The findings provide evidence for the development 
of future interventions to address these aspects. These may include: 1. Early warning systems 
or screening tools based on the quantitative factors, leading to earlier engagement with relevant 
services such as palliative care; and, 2. Support for healthcare professionals in exploring patients’ 
interpretation of their symptoms and disease-related anxiety. 
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1.1 Cancer  
1.1.1 Definition and Terminology 
Cancer is one of the most common causes of morbidity and mortality worldwide (1). Defined by 
Ruddon (2) as the ‘abnormal and unregulated growth of cells which ultimately can invade tissues 
and metastasise to distant sites’ (p. 4), cases of cancer have been described across the globe and 
throughout time (Figure 1.1) (3, 4).  
 
Figure 1.1: Rembrandt’s ‘Bathsheba Bathing’ (1654).  
Oil-on-canvas painting believed to depict early breast cancer by the blue mark painted on Bathsheba’s 
left breast (4). 
The term cancer represents a large variety of disease sub-groups. To date more than 200 distinct 
cancer types have been identified with their classification based on both the underlying cell 
histology and location within the body. The International Statistical Classification of Diseases 
and Related Health Problems (ICD), published by the World Health Organisation (WHO), is the 
 17 
 
most widely used medical classification of diseases, signs and symptoms, abnormal findings and 
external causes of injury (5). The tenth (and most recent) revision, ICD-10, contains 12,420 
different alphanumeric codes, with Chapter II (Neoplasms: codes C00 – D48) specific to the 
classification of cancers (6). 
1.1.2 Disease Trajectory 
In its earliest form cancer represents a focus of abnormal cells in which the process of cell 
division has become disrupted and unregulated (2). At this initial stage most patients remain 
physically well, and if present, symptoms tend to be mild and related to the location of the 
cancer within the body, for example a person with lung cancer may develop a cough. As cell 
replication continues, malignant cells begin to invade neighbouring structures and/or spread 
(metastasise) to areas distant from the original site. This stage of cancer varies considerably 
between individuals and by cancer type. In the advanced and final stages of cancer a relatively 
rapid deterioration in health generally occurs, regardless of cancer type. This stage is 
characterised by a precipitous decline in function, greater level of symptom burden and overall 
reduction in health-related quality-of-life (7, 8). This period of time (weeks to short months) is 
commonly referred to as the ‘end-of-life’.  
Compared to other common causes of death, such as heart failure or chronic obstructive 
pulmonary disease (COPD), the end-of-life decline from cancer is more predictable and sudden 
acute deaths occur relatively infrequently (7, 9). This more foreseeable end-of-life decline allows 
healthcare professionals to anticipate death, and therefore engage in timelier – and as a 
consequence often more meaningful – conversations with patients concerning their preferences 
for end-of-life care. For many, these discussions provide a valuable gift – the chance to express 




In 2012 there were an estimated 14.1 million new cases of cancer, 8.2 million cancer deaths 
(accounting for approximately 14% of global mortality) and 32.6 million people living with cancer 
worldwide (10). In the United Kingdom (UK), new cases of cancer were estimated at 327,000 
and deaths from cancer at 158,000 (representing approximately 28% of annual mortality) (10).  
With the effects of population growth and ageing, mortality from cancer, which is predominantly 
a disease of older persons, is anticipated to rise further. Between 2012 and 2030 global cancer 
mortality is predicted to increase by 37% (10), while in the UK, mortality rates are expected to 
rise 22% from 158,000 deaths in 2012 to an anticipated 193,000 deaths by 2030 (Figure 1.2) 
(11). Issues pertaining to end-of-life care are consequently affecting a greater number of cancer 
patients each year, and the importance of providing high-quality care, in accordance with 
patients’ needs and preferences, is increasingly recognised (12). 
 
Figure 1.2: Number of UK deaths from cancer (2000 to 2030)  
Data based on actual and predicted figures (11) 
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1.2 End-of-Life Care for People with Cancer 
Towards the end-of-life people with cancer wish to be comfortable, be treated respectfully and 
holistically by healthcare professionals they trust, and have an opportunity to achieve a sense 
of completion (13-16). Most (64-84%) prefer to be cared for and die at home, and to avoid overly 
‘aggressive’ care, which can be defined as care that focuses mostly, or exclusively, on disease-
modifying treatments at the expense of good symptom management and/or advance care 
planning (14-18). 
In England, the importance of providing high-quality end-of-life care has been promoted via a 
number of initiatives, such as the Gold Standards Framework (19) and the Department of 
Health’s End of Life Care Strategy (20). More recently, the National Institute for Health and Care 
Excellence (NICE) published an End of Life Care Quality Standard which provides a description of 
what high-quality end-of-life care should look like (21). However, despite increasing guidance, 
establishing and evaluating end-of-life care quality is challenging. National Health Service (NHS) 
England (22) defines high-quality care as that which is ‘clinically effective, safe, and provides as 
positive an experience for patients as possible’ (p. 4). Quantifying the quality of healthcare 
delivered therefore requires the evaluation of patient outcome and/or experience data. In the 
UK, NHS hospitals now routinely collect certain outcomes data with several measures requiring 
mandatory reporting to central government health bodies, for example hospital acquired 
infection rates (23). For oncology services, outcome measures include those relating to cancer 
waiting times, diagnostic imaging, radiotherapy and chemotherapy (24).  
Towards the end-of-life many commonly used outcome measures, such as length of survival, 
become no longer appropriate, as the focus of care shifts away from life-extending treatments 
towards maximising the quality of life remaining. Quantifying the intensity or aggressiveness of 
end-of-life cancer care is especially challenging. Disease-related complications, adverse effects 
 20 
 
of treatment and/or unrelated health conditions are all commonly experienced by patients with 
advanced cancer. In order to be optimally managed, many of these situations require emergency 
department (ED) care and/or admission to hospital, for example an acutely delirious patient who 
cannot be managed safely at home. Deciding which visits, investigations and/or treatments 
represent high-quality end-of-life care versus those that signify overly intensive or aggressive 
care is difficult, as high-quality care for one patient may be considered overly aggressive by 
another (25). To address this issue, in 2003, Earle and colleagues developed a set of quality 
indicators which at a population-level could be used to identify healthcare systems delivering 
overly aggressive end-of-life cancer care. The process involved a literature review to identify 
potential indicators of overly aggressive end-of-life care, focus groups with cancer patients and 
their caregivers to assess these indicators and generate further ideas, and then an expert panel 
who ranked the meaningfulness and importance of each indicator using a modified Delphi 
approach (15). The process identified three concepts of poor quality end-of-life cancer care: 1. 
The institution of new anti-cancer therapies or continuation of ongoing treatments very near to 
death; 2. A high number of ED visits, in-patient hospital admissions, or days spent in intensive 
care near the end-of-life; and, 3. A high proportion of patients never enrolled in hospice care, 
only admitted in the last few days of life, or dying in an acute healthcare setting (15). Further 
evaluation using Medicare claims data from 48,906 cancer decedents resulted in eight specific 
performance measures and accompanying benchmarking figures (Table 1.1) (26). With end-of-
life care now a recognised component of overall cancer care excellence (12), these performance 
measures have been adopted throughout the United States of America (USA) and by other 
countries, for example Qatar, as part of their cancer service monitoring and evaluation (27). In 
2012, five of the measures were endorsed by the National Quality Forum (NQF), USA. 
Collectively, the five measures endorsed focus on the overtreatment of terminally ill patients 
and utilisation of acute healthcare services towards the end-of-life (28). To date, these 
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performance measures have not been used to examine the quality of end-of-life cancer care in 
England. 
























































Proportion receiving chemotherapy in the 
last 14 days of life* 
<0.10 0.92 0.94 0.92 2.24 (1.74-2.97) 
Proportion starting a new chemotherapy 
regimen in the last 30 days of life 
<0.02 0.83 0.94 0.85 3.19 (2.03-5.41) 
>1 emergency room visit in the last month 
of life* 
<0.04 0.82 0.96 0.89 2.78 (2.04-3.88) 
>1 hospitalisation in the last month of life <0.04 0.96 1.00 0.97 2.38 (1.85-3.16) 
Admission to the ICU in the last month of 
life* 
<0.04 0.87 0.97 0.95 3.28 (2.38-4.67) 
Death in an acute care hospital <0.17 0.95 1.00 0.97 2.49 (2.05-3.12) 
Lack of admission to hospice* <0.45 0.24 0.96 0.88 5.00 (3.76-6.89) 
Admission to hospice <3 days before 
death* 
<0.08 0.97 1.00 0.97 2.39 (1.99-2.95) 
Accuracy, the % agreement within +/- 1 day; benchmark, the performance of the top decile of health care 
service areas; CI, confidence interval; ICU, intensive care unit; sensitivity and specificity refers to claims, 
compared with medical record review as the gold standard; variability, ration of adjusted rates in the 5th 
and 95th percentile health care services areas. *Performance measure endorsed by the National Quality 
Forum, USA (26). 
This study seeks to improve the quality of end-of-life cancer care by focusing on one of these 
NQF endorsed performance measures – the proportion of cancer patients with >1 ED visit in the 




2.1 The Emergency Department 
2.1.1 Definition 
Emergency departments (EDs) are medical treatment facilities, typically found in hospitals, 
which specialise in the urgent and immediate care of those who present without prior 
appointment. In England, the majority of EDs are ‘Type 1’ or ‘Major’ departments. These provide 
24-hour consultant led care with full resuscitation facilities and designated accommodation for 
the receipt of accident and emergency patients (29). 
2.1.2 Emergency Department Care 
By virtue of the service they provide – discrete episodes of urgent and immediate care – EDs are 
typically busy, highly pressurised environments; consequently, they are often unsuitable for the 
delivery of high-quality care to patients with chronic and/or complex medical conditions, such 
as those with advanced cancer. Continuity of care is lost with presentation to EDs, something 
valued by advanced cancer patients who would prefer direct admission to an oncology unit or 
treatment at home if given the choice (30, 31). Studies also suggest that many ED physicians feel 
under-qualified when treating patients with palliative care needs, many of whom have complex 
medical requirements that have historically not been part of emergency physician specialist 
training (32-35). From their analysis of 24 semi-structured qualitative interviews with emergency 
physician specialist trainees, Stone et al. (32) noted that staff members lacked communication 
skills to deal with end-of-life care issues and described how ED physicians felt providing end-of-
life care to be at odds with their training “to cure and fix things” (p. 1334).  
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Practical issues, for example the risk of exposure to infection, makes the ED environment 
unsatisfactory for cancer patients, many of whom are immunocompromised due to their 
advanced disease state and/or treatment. Furthermore, ED overcrowding continues to be a 
problem despite an association with poor patient and caregiver outcomes and overall 
dissatisfaction with care (36-38). In a qualitative descriptive study of the experiences of ED 
overcrowding in Dublin, Ireland, Coughlan and Corry (38) reported one patient describing the 
experience as: “like a scene out of a third world country or you know somewhere where a huge 
disaster had taken place – everyone was crammed into the one area” (p. 204). The same patient 
who had attended the ED with a fever following chemotherapy also described the lack of 
cleanliness: “he [doctor] had to get down on the floor beside me. The dishes he was using were 
put on the floor, and it was like the Grand National people jumping over them........the place was 
quite grubby” (p. 204).  
From a societal perspective, ED utilisation is of particular relevance due to the high costs 
associated with providing such care (39-41). The greater expense would be less concerning if it 
improved outcomes for cancer patients and their caregivers, however, evidence suggests this is 
not the case. Instead, concerns have been raised regarding the ‘high cost of dying’ and 
‘disproportionately’ greater healthcare expenditure for cancer decedents than survivors (42-
44).  
In attempting to reduce overall ED attendance, many NHS immediate care services have 
undergone substantial change. For example, new general practitioner (GP) walk-in centres, 
telephone advice services and extended healthcare practitioner roles have all been created (45-
49). To date, however, the impact of such initiatives has been limited, and ED attendance has 
continued to rise (29). In England, the annual incidence of ED visits increased from 12,318,051 
in 2007-08 to 18,328,896 in 2012-13; a rise of 32.8% (29). For people with cancer an upward 
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trend in end-of-life ED visits has also been observed. In Canada, Ho et al. noted that the 
proportion of cancer patients with multiple ED visits in the last 30 days of life increased from 
8.6% in 1993 to 10.5% in 2004 (p<0.01) (50). In the USA, Earle et al. reported similar findings 
with the proportion of cancer patients experiencing multiple end-of-life ED visits increasing from 
7.2% in 1993 to 9.2% in 1996 (p<0.001) (51). 
When considering why these healthcare initiatives have been unable to reduce ED attendance, 
two key features have been identified:  
1) The lack of service-user involvement when developing and implementing new healthcare 
services (45, 52).  
2) An incomplete understanding of the complexity of real world healthcare utilisation by 
patients and/or their significant others (53).  
Healthcare professionals and patients often judge the severity and/or urgency of clinical 
conditions very differently. In a review of studies investigating ‘inappropriate’ ED attendance, 
Penson et al. found that most ED attendees labelled as ‘inappropriate’ by healthcare 
professionals thought they were attending appropriately, for example 32% believed they 
required an X-ray (52). Furthermore, discrepancy between healthcare professionals’ and service 
users’ knowledge of the availability of healthcare services was highlighted by Rosenstock, who 
stated that ‘people can only act on what they believe to exist, even though this may not match 
a healthcare professionals’ viewpoint’ (54).  
To be successful, any future intervention seeking to reduce ED visits must carefully consider 
service-users’ self-perceived needs and understand the complex process by which different 
factors can influence patients’ health-seeking behaviour.  
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2.2 Health-Seeking Behaviour 
Many different factors have been shown to influence patients’ decisions regarding the utilisation 
of healthcare services, and models of health-seeking behaviour can be useful when seeking to 
understand ED attendance by people with cancer. The most widely acknowledged and arguably 
most important theory of health-seeking behaviour is the Behavioural Model of Health Services 
Use developed by Ronald Andersen in 1968 and subsequently published with John F. Newman 
in 1973 (55). Although initially developed to explain general population non-discriminative 
healthcare use, the model has since been applied to many different services and/or populations 
(56-58). The model presents healthcare use as a function of need, enabling resources and 
predisposing characteristics (Figure 2.1). 
 
Figure 2.1: Version 4 of Andersen's Behavioural Model of Health Services Use (58) 
In addition to Andersen’s Behavioural Model of Health Services Use, the Choice-Making Model 
developed by Young and the Adaptive Decision Maker Model by Payne, Bettman and Johnson, 
also provide frameworks to explain healthcare use (59, 60). Young’s Choice-Making Model was 
developed from his extensive ethnographic work in two Mexican villages and incorporates 
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patients’ perceptions of their illness, their knowledge and faith in treatment, and their level of 
access to healthcare resources (59), whereas the Adaptive Decision Maker Model describes how 
individuals make decisions based on a highly complex system of information processing and 
weighing-up of alternative options (60). Each of these models identify important concepts that 
influence patients’ use of healthcare services. Whilst none of the models have been applied to 
people with advanced cancer or at the end-of-life, concepts identified from the models were 
used as an initial framework from which to further explore the topic of end-of-life ED attendance 
by people with cancer. This investigation began with a systematic literature review, the aim of 
which was to identify factors associated with ED attendance by patients with cancer in the last 
month of life. The findings of this review are presented below in the form of a published paper. 
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2.3 Emergency Department Attendance by Patients with Cancer in Their Last 













































2.4 Summary of Background and Rationale for Study 
Despite advances in prevention, early detection and treatment, cancer remains one of the 
commonest causes of morbidity and mortality worldwide (1). With population growth and 
ageing, the number of deaths from cancer is anticipated to rise (10), and the importance of 
providing high-quality end-of-life care, in accordance with patients’ needs and preferences, is 
increasingly recognised (12). 
Towards the end-of-life, people with cancer wish to be comfortable, be treated respectfully and 
holistically by healthcare professionals they trust, and have an opportunity to achieve a sense 
of completion (13-16). Most (64-84%) prefer to be cared for and die at home, and to avoid overly 
‘intensive’ or ‘aggressive’ care, which can be defined as care that focuses mostly or exclusively 
on disease-modifying treatments at the expense of good symptom management and/or 
advance care planning (14-18). One validated marker of overly aggressive end-of-life cancer care 
is the proportion of patients with multiple (≥2) ED visits during their last month of life. ED visits 
are associated with an increased risk of poor patient and caregiver outcomes, such as prolonged 
pain, an overall dissatisfaction with care, and an increased risk of psychiatric illness in bereaved 
relatives (61-63). From a societal perspective, ED utilisation is of particular relevance due to the 
high costs associated with providing such care and ongoing capacity concerns for many EDs 
across developed countries (36, 37, 39). Yet despite the above, end-of-life ED visits by people 
with cancer are increasing over time (50, 51). This situation not only fails many patients and their 
caregivers in the delivery of high-quality end-of-life care, but is unsustainable given the 
predicted increases in cancer prevalence (11, 64). Reducing ED attendance must not be at the 
expense of promoting appropriate attendance for those in need; however, targeting patients 
whose attendance may be classed as avoidable and providing alternative, more suitable care 
pathways is desirable.  
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At present there is limited understanding of cancer patients’ end-of-life ED use. Most of the 
existing research has focused on quantifying attendance and/or investigating factors associated 
with an increased risk of multiple ED visits towards the end-of-life (65, 66). Whilst these studies 
have identified various socio-demographic, clinical and environmental risk factors, important 
gaps in the literature have also been highlighted. Data from the UK, with its unique publicly 
funded model of healthcare delivery, is absent. There is also limited and/or conflicting results 
for several factors, such as patients’ level of co-morbidity, cancer diagnosis and rurality of usual 
place of residence. Qualitative research exploring why advanced cancer patients decide to 
attend the ED is limited (67, 68). Furthermore, an integrated summary of the factors associated 
with end-of-life ED visits (quantitative research) and the decision-making processes of advanced 




2.5 Aim and Objectives 
2.5.1 Aim 
To understand variation in cancer patients’ end-of-life (last month) ED use in order to support 
the development of future initiatives aimed at reducing high attendance and improving equity 
of access to end-of-life healthcare services.  
2.5.2 Objectives 
1) To describe ED use by patients with cancer towards the end-of-life and determine the 
relationship between number of ED visits and socio-demographic, clinical and 
environmental factors.  
2) To explore advanced cancer patients’ and their caregivers’ decisions to seek ED care, and 
understand the issues that influence the decision-making process. 
3) To integrate the findings from objectives 1 and 2 in order to develop a conceptual model of 
advanced cancer patients’ ED use, from which key elements to inform future service 
development can be identified.  
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 Study Design and Overview of Methods 
In order to address the research aim and objectives a mixed methods study with a concurrent 
triangulation design was planned (Figure 3.1) (69). These comprised: 
1) Secondary analysis of pooled data from two mortality follow-back studies: the 
QUALYCARE study (UK Clinical Research Network (CRN) ID 7041) (70) and the 
International Access, Rights and Empowerment (IARE) study (UK CRN ID 11879) (71). 
2) A population-based retrospective cohort study using linked patient-level data from the 
Office for National Statistics (ONS) and Hospital Episode Statistics (HES): dataset 
supplied by NHS Digital (72).  
3) A qualitative interview study with data collected via semi-structured patient and 





Figure 3.1: Overview of study design and relationship to objectives 
Methods 
Interaction occurred at the level of data analysis; quantitative findings informed 
issues explored during qualitative interviews and themes emerging from the 
qualitative interviews guided further analysis of the quantitative dataset. 
Quantitative Strand: 
Component 1  
Secondary analysis of pooled data 
from two mortality follow-back 
studies: the QUALYCARE study (UK 
CRN ID 7041) and the International 
Access, Rights and  
Empowerment study (UK CRN ID 
11879).  
[OBJECTIVE 1] 
[PUBLICATION 2 – Chapter 4] 
Qualitative Strand  
A qualitative interview study with 
data collected through semi-
structured patient and caregiver 
interviews, and review of patients’ 
healthcare records. 
[OBJECTIVE 2] 
[PUBLICATION 4 – Chapter 6] 
Quantitative Strand: 
Component 2  
A population-based retrospective 
cohort study using linked patient-
level data from the ONS and HES: 
dataset supplied by NHS Digital.  
[OBJECTIVE 1] 
[PUBLICATION 3 – Chapter 5] 
Background 
Systematic review and meta-analysis with findings used to develop a conceptual 
framework for the mixed methods study.  
[PUBLICATION 1 – Chapter 2 section 3] 
 
Aim 
To understand variation in cancer patients’ end-of-life (last month) ED use in 
order to support the development of future initiatives aimed at reducing high 
attendance and improving equity of access to end-of-life healthcare services. 
Integration and Discussion [OBJECTIVE 3] 
Findings from both strands combined, interpreted and overall conclusions made. 
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3.1 Mixed Methods Research 
3.1.1 Definition 
Creswell (69) defines mixed methods research as ‘an approach to inquiry that combines or 
associates both qualitative and quantitative forms. It involves philosophical assumptions, the 
use of qualitative and quantitative approaches, and the mixing of both approaches in a study’ 
(p.4). By utilising the strengths of both quantitative and qualitative approaches, mixed methods 
research is especially useful when investigating complex behavioural and/or clinical phenomena, 
such as ED use, where a single method approach would be unlikely to capture the totality of the 
study subject (73, 74). 
3.1.2 The Choice of Mixed Methods 
For this study the decision to use mixed methods was largely determined by the complexity of 
the research topic and its overall aim and objectives. Quantitative methods were used to 
describe and investigate cancer patients’ end-of-life ED use according to multiple independent 
factors (objective 1). To understand how and why these factors influenced cancer patients’ ED 
use, qualitative methods were adopted, allowing an exploration of cancer patients’ thought 
processes and decision-making (objective 2). When combined, the quantitative and qualitative 
findings provided different but complementary data concerning cancer patients’ end-of-life ED 
use. Integration ultimately enhanced the understanding of the study subject and resulted in 
knowledge that was greater than the sum of the individual parts (objective 3) (74). 
3.1.3 Theoretical Considerations when using Mixed Methods 
The use of mixed methods in research has increased over recent years and now offers a 
recognised approach for investigating diverse health and social care issues. Yet despite growing 
acceptability philosophical debates remain, mostly regarding how to combine and interpret 
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knowledge gained from research methods associated with very different and classically 
conflicting research paradigms. Quantitative research is traditionally associated with positivism.  
A positivist believes in a single reality which can be measured and known, and ‘adheres to the 
view that only “factual” knowledge gained through observation (the senses), including 
measurement, is trustworthy’ (75). In comparison, qualitative research is most commonly 
associated with interpretivism or constructivism. Interpretivists do not believe in a single reality 
or truth, rather they adopt a more flexible approach to research, believing that reality is created 
by individuals and therefore requires interpretation (69).  
The research philosophy in which the present study was conducted was one of realism. Realism 
acknowledges the existence of an objective reality (one that is independent of human 
construction and can be counted), however it also accepts that knowledge and understanding 
of this ‘real’ world is derived from one’s personal thoughts and experiences (76). Whilst realism 
rejects the idea of multiple realities, it is compatible with the idea that there are different and 
valid perspectives of a single reality, and consequently reasons that an approach which gains 
multiple vantages ought to ultimately result in more complete knowledge and understanding 
(76).  
3.2 Methodological Challenges and Considerations 
The following section of this thesis describes some of the methodological challenges 
encountered whilst undertaking this research. The ethical approvals required for each study 
component are also presented. A more detailed description of the research methods can be 
found in each study component’s corresponding publication (Chapters 4 to 6).  
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3.2.1 Quantitative Strand 
Whilst the final quantitative strand of this study consisted of two components, the initial design 
proposed included only one, a population-based retrospective cohort study. This preliminary 
design was revised after encountering considerable challenges in acquiring the requested 
dataset from NHS Digital (formerly the Health and Social Care Information Centre (HSCIC)). The 
study design revisions resulted in an additional analysis being conducted prior to the 
retrospective cohort study. This additional secondary analysis used pooled data from two 
mortality follow-back surveys (Figure 3.1). 
3.2.2 NHS Digital Data Acquisition Challenges 
Sponsored by the Department of Health, UK, NHS Digital provide commissioners, analysts and 
healthcare staff with access to a wide range of data products, information services and systems 
(77). Their products include HES, a data repository of patient-level activity occurring across NHS 
hospitals in England. They also offer a linkage service between their own data products and 
those of other national bodies, such as the ONS. Under usual circumstances, data applications 
to NHS Digital take up to 60 days to be processed (78).  
In September 2013, an application for linked ONS HES data was submitted to NHS Digital; 
however, shortly after this application, NHS Digital commenced an internal review of all their 
data release policies in response to an NHS patient data audit which raised concerns about their 
use of public information (79). Amongst the audit findings was evidence of ‘lapses in the strict 
arrangements that were supposed to be in place to ensure that people's personal data would 
never be used improperly’ (80). Whilst an internal review took place and changes to NHS Digital’s 
data handling processes were implemented, lengthy delays were experienced by all data 
applicants. Copies of the original data application form and email correspondence with NHS 
Digital can be found in Appendix A.  
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The dataset requested from NHS Digital was finally received in December 2014, some 15 months 
after the original application was submitted. Analysis was completed according to the original 
protocol and is presented in the form of a published paper in Chapter 5. However, due to the 
extensive delays and uncertainty regarding when the data would become available, in April 2014 
it was elected to explore alternative datasets also suitable of addressing the study’s quantitative 
objective (objective 1). After considering different options it was decided to pool data from two 
recently conducted mortality follow-back surveys: the QUALYCARE study (UK CRN ID 7041) (70) 
and the IARE study (UK CRN ID 11879) (71). In both studies patients’ bereaved 
relatives/significant others were surveyed via a postal questionnaire regarding the care received 
by their family member/friend during the last three months of life. The questionnaire used was 
initially developed for the QUALYCARE study and then later adapted for use by the IARE study. 
Both versions included the same two questions concerning ED attendance: ‘We would like to 
know about the care your relative or friend received during the last 3 months before he/she 
died. Did he/she visit an Accident & Emergency (A&E) department? & How many times?’. 
3.2.3 Strengths and Limitations of the Additional Quantitative Analysis 
During planning of the additional analysis three main benefits were recognised. Firstly, the 
mortality follow-back surveys contained several community healthcare service variables, such 
as GP home visits, district nursing and contact with palliative care services, which were not 
available from NHS Digital. Secondly, the pooled dataset was considerably smaller than the 
dataset requested from NHS Digital (n=681 versus n=124,030 and 103 variables versus 332). 
Cleaning of the dataset was therefore quicker than anticipated and meant that in addition to 
investigating the relationship between multiple factors and end-of-life ED visits, the relationship 
with other recognised indicators of overly aggressive end-of-life cancer care, for example place 
of death, could also be explored. Lastly, the additional analysis provided me with an opportunity 
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to improve my statistical analysis skills and use of the statistical data package Stata/IC 13 (STATA, 
College Station, Tx). 
It was also recognised that the additional analysis would have limitations. Both mortality follow-
back surveys asked about cancer patients’ ED use in the last three months of life – an outcome 
which was different to the planned analysis exploring cancer patients’ ED use in the last month 
of life. This latter time period was specifically chosen as the prevalence of ED visits during the 
last month of life is a recognised and validated indicator of overly aggressive end-of-life cancer 
care, for which benchmarking data is also available (26). It was acknowledged that this is not the 
case for ED visits in the last three months of life. The study settings and populations also differed; 
whilst the NHS Digital dataset was population-based (comprising all adults who died from cancer 
in England during a one year period), the mortality follow-back surveys consisted of data from a 
sample of patients who had died from cancer across four London boroughs, therefore limiting 
generalisability. Despite these limitations it was felt that the additional knowledge gained from 
the mortality follow-back surveys was important and relevant to understanding cancer patients’ 
end-of-life ED use. The analysis was therefore included with the population-based cohort study 
in the presentation of the final research findings. 
3.3 Ethics 
3.3.1 Quantitative Strand: Component 1 
Ethical approval had been granted for both the original QUALYCARE and IARE studies. Prior to 
conducting any further analysis, the protocols for both studies were reviewed to determine 
whether the additional analysis proposed fell within the scope of the original projects’ aims and 
objectives. After this was confirmed, all National Research Ethics Committee data requirements, 
such as confidentiality agreements, were fulfilled (Appendix B). 
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3.3.2 Quantitative Strand: Component 2 
For the population-based retrospective cohort study, approval was received from NHS Digital 
who also extracted and provided the bespoke data-linked dataset (reference number: NIC-
223311-Z0B8Q). As all data was pseudonymised, and therefore non-identifiable, no further 
ethical approvals were required to complete the analysis (Appendix C).  
Quantitative Data Management 
Data was managed in a strictly confidential manner and in accordance with all relevant policy 
documents for handling sensitive and/or personal information. This included data being 
encrypted and stored on a secure password-protected system, only accessible by those 
individuals named in the data agreement contracts. Information shared with third parties, such 
as data submitted to journals for publication, had all identifying details removed. Low counts 
(n<10) were also suppressed in-line with good data handling practice and requirements from 
NHS Digital regarding data reporting. 
3.3.3 Qualitative Strand 
Ethical approval for the qualitative interview study was received from the National Research 
Ethics Service Committee South Central – Berkshire (research ethics committee reference 
14/SC/1207) and the Research and Development Office at King’s College Hospital (reference 
KCH14-171). Copies of the research and ethics committee application and corresponding 
approval documents can be found in Appendix D. 
Ethical Considerations 
There is a substantial and growing body of evidence, including two systematic reviews, of the 
benefits experienced by individuals with life-limiting conditions from participating in research 
(81, 82). However, despite these benefits, conducting research in vulnerable populations, such 
as those with terminal illnesses, requires particular thought and consideration. In-depth 
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research interviews may uncover new or inadequately managed health and/or psycho-social 
concerns. Some participants may also find elements of the interview process distressing. Prior 
to the qualitative interview study commencing these issues were carefully considered and plans 
were made to reduce potential sources of distress. To help them feel as comfortable as possible, 
participants were offered a choice of interviews settings, including their own home. A distress 
protocol was also developed based on those successfully used by previous qualitative 
researchers in the Division of Palliative Care, Policy & Rehabilitation, King’s College London 
(Appendix E). During the interviews participants were monitored for signs of distress, breaks 
were incorporated and interviews ended early if needed.  
As well as the impact of qualitative research on study participants, the interaction between 
researchers and the study process also requires consideration. Qualitative inquiry requires 
researchers to closely engage with both their study participants and the research process. 
Consequently, it is acknowledged that when conducting qualitative studies researchers’ 
personal experiences and/or biases cannot be completely without influence. To improve the 
credibility of qualitative findings researchers should make attempts to minimise any potential 
biases. They should also recognise and clarify for other readers elements about themselves that 
may have influenced their participation in the research process, for example their occupation, 
experience and/or training (83). For these reasons, I offer the following short autobiography and 
personal reflections on how my individual characteristics may have influenced the research 
process and/or study findings. 
Autobiography 
I was born in Cardiff, Wales, in 1981, to an American mother and English father; I am the middle 
daughter of three children. Following my A-Levels I went to London to study medicine at Guy’s, 
King’s and St Thomas’ School of Medicine and Biomedical Sciences. I graduated in 2005 and 
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spent the next four years working as a junior doctor across London and the South East. During 
this time I completed my Membership of the Royal College of Physicians (MRCP) and also made 
the decision to pursue a career in palliative care. I started specialist palliative care training in 
October 2009, with my first two years spent working in rural hospices in England: Pilgrim’s 
Hospice, Canterbury, and Hospice in the Weald, Tunbridge Wells. I then made the decision to 
take a 12-month break from formal registrar training to volunteer as a Palliative Care Clinical 
Research Fellow at Mulago Hospital, Kampala, Uganda. Whilst working in Uganda I had the 
opportunity to assist with a number of different research projects, including a qualitative 
evaluation of a palliative care pilot project in the Lake Zone of Tanzania (84). This experience, 
and the fulfilment I found using my clinical knowledge in a research capacity, made me want to 
continue working in an academic setting. Towards the end of my year in Uganda I began looking 
for further opportunities to develop my research knowledge and skills, including the possibility 
of conducting my own supervised research project through a PhD fellowship. These plans 
became reality in September 2012 when I proudly accepted the position of BuildCARE PhD 
Clinical Training Fellow at the Cicely Saunders Institute, Division of Palliative Care, Policy & 
Rehabilitation, King’s College London.  
Influence of Personal Characteristics on Research Process and Study Findings 
Social, cultural and personal characteristics inevitably shape relationships, including those that 
develop as part of a research study. Rather than trying to prevent this from happening, 
researchers should recognise these situations and explore how they may be affecting the 
findings of the study. For this qualitative interview study, I explained to participants that I was 
working with the palliative care or acute oncology team at King’s College Hospital to conduct a 
study about decisions to seek ED care. No further information about myself or the research team 
was offered; however, I replied honestly to any participants who asked me about my profession. 
I believe that my position as a doctor, as well as my age, gender and ethnicity, had some degree 
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of influence on the study conduct and its findings. As a doctor I was viewed by some participants 
as having knowledge and/or being in a position of power. As a consequence, social desirability 
may have influenced some of the answers given and/or impacted what information participants 
felt able to share. Characteristics, such as my age, gender and ethnicity, meant I established a 
rapport with some participants more easily than others. This mostly offered an advantage, 
allowing me to engage with participants and introduce difficult topics of conversation more 
easily. However, it also meant that there were times when I took for granted certain aspects of 
participants’ narratives, believing there was a shared meaning and understanding. 
Reflections on the Qualitative Interview Process 
At the start of my PhD fellowship I had limited research experience. Despite additional training, 
the qualitative interview study involved a steep learning curve. After completing my first three 
interviews I spent time reviewing the transcripts and discussing their content with my PhD 
supervisors. I found that whilst these interviews had generated large volumes of data, the issues 
discussed were rather predictable and lacked the depth and richness of information required. 
There were times when I interrupted the participant and/or used leading questions. I also spent 
too much time clarifying small details in order to find the most accurate account of events, 
rather than focusing on the language used by participants and the way in which important issues 
were being described. As a palliative care registrar I have received training in advanced 
communication skills and have extensive experience of ‘interviewing’ patients through clinical 
history taking. This background provided me with relevant and transferable skills, including the 
ability to build a rapport with participants and engage in conversations about sensitive issues, 
such as death and dying. However, almost all these experiences have been in relation to clinical 
encounters where the interview style and purpose is very different. Doctor-patient interviews 
stem from a bio-medical model of health, where ‘although the doctor may be willing to see the 
problem from the patient's perspective, the clinical task is to fit that problem into an appropriate 
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medical category in order to choose an appropriate form of management’ (85, 86). Appreciating 
these fundamental differences helped me develop a more exploratory style of interviewing, and 
I began to realise the depth of information behind what I previously might have considered 
straight forward statements of fact. Following feedback, I learned to assume less and prompt 
more; I began asking fewer questions and instead focused on how participants described and 
interpreted their realities. Overall, the process was enlightening, and has made me a better 
qualitative researcher and more insightful palliative care physician.  
3.4 Presentation of Results 
The results of this study are presented in the form of three published papers. The first two 
publications address objective 1 and collectively represent the quantitative strand of this study. 
The third publication addresses objective 2 and represents the qualitative strand. Objective 3 is 
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 Integration and Discussion 
7.1 Overview 
The overall aim of this study was to understand variation in cancer patients’ end-of-life ED use 
in order to support the development of future initiatives aimed at reducing high attendance and 
improving equity of access to end-of-life healthcare services. A review of the scientific literature 
revealed a limited understanding of cancer patients’ end-of-life ED use. Most of the existing 
research focused on quantifying attendance and/or investigating factors associated with an 
increased risk of multiple ED visits towards the end-of-life (65, 66). Whilst these studies 
identified various socio-demographic, clinical and environmental risk factors, important gaps in 
the literature were highlighted. Data from the UK, with its unique publicly funded model of 
healthcare delivery, was absent. There were also limited and/or conflicting results for several 
factors, such as patients’ level of co-morbidity, cancer diagnosis and rurality of usual place of 
residence. Qualitative research exploring why advanced cancer patients decide to attend the ED 
was limited (67, 68). Moreover, an integrated summary of the factors associated with end-of-
life ED visits (quantitative research) and the decision-making processes of advanced cancer 
patients to seek ED care (qualitative research) was lacking.  
This mixed methods study was designed to address these gaps: quantitative methods were used 
to investigate factors associated with end-of-life ED visits by people with cancer in England, UK 
(Publications 2 and 3); a qualitative interview study was conducted to explore advanced cancer 
patients’ and their caregivers’ decisions to seek ED care (Publication 4). This chapter combines 
the quantitative and qualitative findings, and discusses the relevance of the integrated findings 
to clinical practice, policy and service development. A conceptual model developed from the 
results is then presented, depicting the main factors and concepts – and the presumed 
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relationships between them – contributing to the phenomenon of cancer patients’ end-of-life 
ED use. 
7.2 Integration 
7.2.1 Demographic Factors  
Demographic differences in end-of-life ED attendance by people with cancer are well reported 
in the literature (87-89). This is exemplified by the findings of the systematic review 
conducted, which found high-quality evidence (meta-analysis) for an increased risk in end-of-
life ED visits for men, younger patients and people of Black ethnicity. The population-based 
retrospective cohort study explored these factors for the first time in a UK population, and the 
findings were consistent with those of the systematic review. Men were found to have an 
increased odds of multiple ED visits during the last month of life (adjusted odds ratio (AOR) 
1.26, 95% confidence interval (CI) 1.19-1.34, reference group female) ( 
Figure 7.1), as were people of Asian or Black ethnicity (AOR 1.49, 95% CI 1.27-1.74 and AOR 1.21, 
95% CI 1.01-1.46 respectively, reference group White ethnicity). Also consistent with the 
systematic review findings was an increased odds of multiple ED visits in the last month of life 
for younger patients. 
The qualitative component of this study further explored these demographic factors. One 
important finding that emerged was the relationship between patients’ age and disease-related 
anxiety. Patients’ anxiety about their cancer was one of four key concepts that emerged from 
the qualitative interviews as influencing patients’ and their caregivers’ decisions to seek ED care; 
and patient’s age appeared to mediate this anxiety. Compared to younger patients, older 
patients described feeling less anxious about their cancer diagnosis and were also less likely to 





Figure 7.1: Forest plot illustrating the effect of sex on cancer patients’ ED attendance in the last month 
of life  
Meta-analysis of odds ratios using random-effects model. (A) Results from systematic review meta-





This is not to say that older persons were less anxious overall, rather, that the issues causing 
anxiety varied across age groups. Whilst younger patients described more anxiety regarding 
physical symptoms and their cancer diagnosis, older patients reported feeling anxious about 
practical day-to-day tasks, such as getting washed and dressed each morning. These differences 
offer one explanation for the quantitative finding that younger patients have an increased risk 
of attending the ED multiple times in the last month of life compared to older patients.  
The qualitative interview study did not provide further insight into the associations found 
between end-of-life ED visits and other demographic factors, i.e. male sex and Asian or Black 
ethnicity. However, as per the findings for age, one hypothesis is that these differences are due 
to varying health beliefs across different ethnic groups and between men and women. This 
hypothesis is supported by studies that have shown differences in symptom perception across 
socio-demographic groups, and those that have found certain health beliefs and behaviours to 
be distributed unequally across society (90, 91). For example, studies have shown that the 
uptake of screening and preventative healthcare appointments is greater for women, younger 
persons and those of White ethnicity (54). An alternative hypothesis is that the quantitative 
variation seen is secondary to different preferences for end-of-life care (92-97). In a survey of 
2,536 patients aged >65 years, Garrett et al. found that after adjustment for factors such as 
marital status, 53% of women had a desire for less treatment if they were to have a terminal 
illness compared to 42% of men (93). With regards to ethnicity, Smith et al. found that African-
American patients with a terminal illness were more likely than White patients to want 
cardiopulmonary resuscitation, dialysis and other life prolonging treatments (98). Furthermore, 
in a multi-site prospective cohort study examining ethnic disparities in advance care planning 
and preferences for end-of-life care, Smith et al. found that African-American patients were less 
likely to acknowledge having a terminal illness and to want to discuss their prognosis compared 
to White patients (99). This study challenges the hypothesis that the demographic variation in 
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end-of-life ED use is secondary to different preferences for care. Firstly, preferences did not 
emerge during the qualitative interviews as a concept influencing patients’ and their caregivers’ 
decisions to seek ED care. Whilst it could be argued that the action of attending the ED, as 
opposed to seeking care elsewhere, was a reflection of patients’ preferences, the qualitative 
interview study did not support this interpretation. Rather, patients described having no other 
option than to attend the ED (quote 1), and some stated a preference not to be in an acute 
hospital setting (quote 2). 
Quote 1: Qualitative interview conducted with participant ED07, an 80-year-old man with 
Acute Myeloid Leukaemia who presented to the ED with a temperature 
LH [interviewer]: Did you want to come to hospital?  
ED07: Hadn’t got any choice ‘cause outpatients said to me if it [temperature] ever goes 
above 38, you’ve gotta come in. (LH: Okay) You’ve gotta come in.  
Quote 2: Qualitative interview conducted with participant ED01, a 66-year-old man with 
Hepatocellular Carcinoma who presented to the ED with abdominal pain 
ED01: Well I think, like I said, on reflection…mmm [pause] acute medical admissions ward 
isn’t the best place (LH [interviewer]: Okay) to be when you’re sitting with this kind of stuff. 
I know everyone’s got their own difficulties, err and maybe other people in here have 
terminal illnesses as well. Erm [pause] but I’ve just felt on occasions you know that, the 
kind of business of the place and err. [pause] I’ve seen some obviously really quite unwell 
people. (LH: Mmm) I’d prefer to be somewhere a bit quieter and alone I think. 
Furthermore, this hypothesis was not supported by the qualitative findings regarding patients’ 
religious/spiritual beliefs. Previous research has identified an association between religious 
beliefs and a desire for more aggressive end-of-life care (100, 101). For example, in a study of 
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patients with advanced cancer who had failed first line chemotherapy, Balboni et al. found an 
association between religiousness and a desire for all measures to extend life (odds ratio (OR) 
1.96, 95% CI 1.08-3.57) (101). However, the qualitative interviews conducted as part of this study 
found that instead of precipitating a decision to attend the ED, religiousness was a mediator of 
disease-related anxiety, and for many patients helped them cope with their illness (quote 3). 
Quote 3: Qualitative interview conducted with participant ED18, a 46-year-old woman with 
metastatic Breast Cancer who presented to the ED with back pain 
ED18: You know I’m I’m a Christian and I’m a believer, I’m I’m I’m a born-again believer 
so…my faith is very strong in in what I believe, and, that really takes care of a lot of the the 
burden if I should say, (LH [interviewer]: Okay) you know. When when I get to a state where 
I get like a bit of a wimp, I pray. 
One explanation for this difference may be the timing of the interviews (post ED attendance) 
and the type of situations being explored (urgent/acute issues) (102, 103). Most of the evidence 
regarding patients’ preferences for end-of-life care comes from survey and questionnaire 
studies which typically ask participants about their preferences for care given various 
hypothetical future scenarios. In reality, preferences for care can change over time and with 
experience of illness (104-108). In a qualitative interview study with people who had experience 
of pancreatic cancer (eight patients; eight bereaved relatives), Chapple et al. found that 
preferences for care were influenced by participants’ prior healthcare experiences (109). This 
study supports those findings and provides further evidence that patients’ prior health-seeking 
behaviour is important in shaping their future use of healthcare services. The population-based 
retrospective cohort study found a dose-response pattern between patients’ prior ED use and 
risk of multiple ED visits in the last month of life (Figure 7.3). Findings from the qualitative 
interview study were complementary; at times of crisis participants’ described defaulting to 
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services they had previously used and were familiar with. Furthermore, the qualitative interview 
study highlighted the complexity of patients’ decision-making and the wide variation in cancer 
patients’ experiences at the end-of-life. Most of the patients interviewed were well informed 
about their diagnosis and many talked candidly about the future and their expectations of death. 
Yet despite having considerable knowledge and insight, most of the events that precipitated 
patients’ and their caregivers’ decisions to attend the ED had not been anticipated or planned 
for.  
Summary of Integrated Demographic Findings 
The integrated findings of this study support previously conducted research showing an 
association between demographic factors (male sex; younger age; Black ethnicity) and an 
increased odds of multiple ED visits in the last month of life. Rather than different preferences 
for end-of-life care, the findings of this study suggest that the variation in end-of-life ED use is 
due to different health beliefs, such as symptom interpretation, across demographic groups. 
7.2.2 Clinical Characteristics 
Level of Co-Morbidity 
Previous studies have explored the relationship between cancer patients’ level of co-morbidity 
and end-of-life ED use (50, 87, 89), and overall, the findings have been mixed. This study found 
a dose-response relationship between cancer patients’ level of co-morbidity and odds of 
multiple ED visits in the last month of life. Compared to patients with a co-morbidity score of 
zero, patients with a score of 1 or ≥2 were more likely to visit the ED multiple times (AOR 1.31, 
95% CI 1.23-1.39 and AOR 1.53, 95% CI 1.43-1.63 respectively). Consistent with these findings 
are those of Ho et al. who found a positive trend between cancer patients’ level of co-morbidity 
and odds of multiple ED visits in the last 30 days of life (50). Similarly, Barbera et al. found that 
patients with a Charlson co-morbidity score of ≥2 were more likely visit the ED in their last two 
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weeks of life compared to those with a score of 0 or 1 (AOR 1.099, 95% CI 1.016-1.189) (89). In 
contrast to these findings were those reported by Seow et al., Maddison et al. and Almaawiy et 
al., all of whom found no significant association between patients’ level of co-morbidity and end-
of-life ED use (87, 110, 111). Further interpretation of these findings is challenging due to the 
variation in how co-morbidity was categorised across studies. The qualitative interview study 
did not identify co-morbidity as a concept influencing cancer patients’ ED use and therefore was 
unable to support or explain the quantitative findings.  
One hypothesis that could explain the mixed results is that the relationship between co-
morbidity and ED use is confounded by patients’ mobility and/or risk of falls. Overall, it appears 
that patients with either low or very high co-morbidity scores are less likely to visit the ED 
towards the end-of-life compared to those with medium or high scores. Patients with low co-
morbidity scores are likely to have a lower risk of falls compared to those with medium or high 
scores. This positive trend between co-morbidity score and risk of falls would continue up until 
a certain threshold point when the number of co-morbidities (corresponding to a very high co-
morbidity score) would correlate with patients becoming chair or bedbound, and consequently 
significantly reducing or eliminating their risk of falls. The quantitative study found that 
musculoskeletal disorders/injuries (including fractures) was the third most common reason for 
patients’ attending the ED in the last month of life. Issues with data quality meant that this 
relationship could not be explored further, however it is possible that part of this relationship 
can be explained by injuries secondary to falls. 
Type of Cancer and Symptoms Experienced 
The retrospective cohort study found that patients with lung or head and neck cancer have an 
increased risk of multiple ED visits in the last month of life (AOR 1.74, 95% CI 1.56-1.95 and 1.67, 
1.40-2.00 respectively, reference group colorectal cancer), and that respiratory symptoms are 
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the most common ED presenting complaint. These findings are in keeping with existing studies 
that have shown an increased risk of multiple ED visits in the last month of life for patients with 
lung cancer (50, 51, 65, 89, 111, 112), and studies that have found breathlessness to be the most 
common presenting symptom of cancer patients who attend the ED or are admitted to hospital 
during their last days of life (113, 114). Less evidence exists for the relationship between end-
of-life ED visits and other cancer types, although individual studies have reported an increased 
likelihood of ED visits for patients with haematological malignancies (50), hepatocellular 
carcinoma and oesophageal cancer (65).  
People with lung cancer may be more likely to visit the ED towards the end-of-life due to the 
speed and pattern with which lung cancer spreads throughout the body. In the UK, just 32% of 
patients diagnosed with lung cancer are alive at one year, compared to 94% and 96% of prostate 
and breast cancer patients respectively (11). When there is a short amount of time between 
diagnosis and death, advance care planning is often more challenging, as patients can still be 
receiving treatment and coming to terms with their diagnosis when their health begins to 
deteriorate. This hypothesis is not, however, supported by patterns of ED use seen with other 
cancers that have a similarly poor prognosis. For example, people diagnosed with pancreatic 
cancer have a 21% chance of survival at one year, but have not been found to have an increased 
risk of multiple end-of-life ED visits. The qualitative interview study expanded on these findings, 
revealing that certain symptoms, in particular breathlessness, were more likely to be interpreted 
as severe and/or requiring urgent review, compared to other symptoms. Although patients with 
many different types of cancer can experience breathlessness, it is most commonly experienced 
by those with lung cancer (115). The relationship between patients’ symptom experiences and 
their ED use is an important area for future research. Unfortunately, issues with data quality 
limited further quantitative analysis of patients’ symptoms in this study.  
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Summary of Integrated Clinical Findings 
The integrated findings of this study support a dose-response relationship between cancer 
patients’ level of co-morbidity and end-of-life ED attendance up until a certain threshold point 
when a very high co-morbidity score reduces risk. This relationship may be confounded by 
patients’ mobility and/or risk of falls. This study also supports previously conducted research 
showing an association between an end-of-life ED visits and a diagnosis of lung cancer, which 
may be related to an increased prevalence of breathlessness in this patient group. 
7.2.3 Environmental Factors 
This study investigated the relationship between cancer patients’ end-of-life ED use and the 
following environmental factors: socio-economic status (SES); community healthcare services; 
contact with palliative care. The relationship between patients’ prior ED attendance and ED visits 
in the last month of life was also determined.  
Socio-Economic Status 
SES is known to correlate with the aggressiveness of end-of-life cancer care including the risk of 
multiple ED visits in the last month of life (116-119). In line with these findings, the retrospective 
cohort study found people with a higher SES had a lower odds of multiple ED visits in the last 
month of life (AOR 0.84, 95% CI 0.77-0.92, reference group lowest SES). The consistency of these 
findings is of particular interest given that these data come from countries with different 
healthcare systems and policy. In the UK, the NHS provides healthcare that is free for all at the 
point of delivery. Yet despite this, significant differences in the aggressiveness of end-of-life 
cancer care based on SES remain. Furthermore, evidence that improvements to the UK’s overall 
delivery of end-of-life care have not reduced inequality across socio-economic groups is 
concerning (120, 121). The qualitative interview study did not provide further insight into this 
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relationship, however, as for demographic factors, a potential mechanism of action could be 
differences in patients’ health beliefs across social class.  
Community Healthcare Services 
The relationship between community healthcare services and ED attendance is important 
especially when considering the structure of future services and policy. Results from the 
secondary analysis of pooled data from two mortality follow-back surveys found that patients 
were more likely to experience an indicator of aggressive end-of-life care if they had: <5 GP 
home visits during their last three months of life (AOR 2.70, 95% CI 1.22–5.88, reference group 
≥5 GP visits); and, no contact with district nursing (AOR 2.08, 95% CI 1.20–3.57, reference group 
district nursing contact). The dataset supplied by NHS Digital did not include any community 
healthcare service variables; therefore, the specific relationship between patients’ ED 
attendance in the last month of life and their use of community healthcare services could not 
be determined. The qualitative interview study did however provide further insight into the 
relationship between patients’ use of community healthcare services and end-of-life ED 
attendance. Access to community healthcare services emerged as a key theme that influenced 
patients’ and their caregivers’ decisions to seek ED care. Participants described difficulties 
accessing community healthcare services, especially urgently and/or out-of-hours. Participants 
also described the hospital setting and staff as more familiar to them than community services 
and staff. Previous studies have identified continuity of care as important to patients’ quality of 
life (14, 122, 123) and their use of healthcare services (111, 124). Whilst the availability of 
community healthcare services is important, so also is healthcare provider continuity and trust; 
patients described their decision-making as being influenced by both. The most striking evidence 
for this came from the divergent findings of one qualitative interview. This interview was 
conducted jointly with the patient and his caregiver (son). Both described a positive and trusting 
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relationship with their GP to the extent that they would always seek their GP’s advice before 
attending the ED (quote 4). 
Quote 4:  Qualitative interview conducted with participant ED17, who was the son of 
participant ED16, an 86-year-old man with Lung Cancer who had recently attended the ED: 
LH [interviewer]: So tell me more about what happened when the GP came. So you 
phoned up, and it sounded like it was quite straightforward.  
ED17: Yeah erm we phoned-up. [phone rings] Sorry I’ll just switch this off. [pause] 
ED17: Erm, yeah we phoned reception, said is there any chance of a home visit? Said he 
was too weak for us to get down to the surgery and yep not a problem, he would come at 
the end of the surgery. He did, turned up…had a quick look over. Told him what the 
symptoms were, what our concerns were, and we said said to him right said this normally 
coincides with needing a transfusion, and he went maybe, we said like his stool’s black and 
he explained that that could be down to the iron which it turned out what it was (LH: Okay) 
and err you know certainly agreed that he definitely needed re-hydrating, and he called 
for the ambulance. (LH: Okay) He didn’t leave us to do it he got onto the surgery and said 
request an ambulance within the next two hours. (LH: Okay). 
Contact with Palliative Care 
The systematic review conducted found high-quality evidence (meta-analysis) of a reduced odds 
of ED visits in the last month of life for cancer patients receiving palliative care (pooled OR 0.43, 
95% CI 0.36-0.51, reference group patients not receiving palliative care) (Figure 7.2). Consistent 
with the systematic review, the secondary analysis of pooled data from two mortality follow-
back surveys found a reduced risk of aggressive end-of-life care for patients who had contact 
with community palliative care services (AOR 0.27, 95% CI 0.15-0.49, reference group no contact 




Figure 7.2: Forest plot illustrating the effect of palliative care services on cancer patients’ ED attendance 
in the last month of life  
Meta-analysis of odds ratios using a random-effects model (125-129). 
The qualitative interview study highlighted a number of different mechanisms by which contact 
with palliative care services might reduce patients’ end-of-life ED use. Firstly, patients reported 
how, at times of crisis, they defaulted to services they had prior experience of and to healthcare 
professionals they trusted. Palliative care helped bridge a transition between patients receiving 
mostly hospital-based care (via the oncology team), to receiving mostly community-based care. 
Rather than there being a distinct handover from one service/specialty to the next, palliative 
care helped support a transition in patients’ care and encouraged relationships that developed 
more naturally over time. 
Secondly, participants described how palliative care services provided them with education and 
support for their symptoms. Even though patients’ perceptions of their symptoms tended to 
remain, education, for example about pain and the use of analgesic medication, meant that it 
was possible for some patients to manage their symptoms out-of-hours and seek help from non-
urgent healthcare services, such as their regular GP, the following day. 
 112 
 
The qualitative findings also identified important times when community palliative care services 
would be unlikely to prevent an ED visit. In particular, the issue of safety and being able to 
abdicate responsibility emerged. Participants described feeling anxious at home and wanting to 
be somewhere ‘safe’. Several participants reported feeling reassured when practical tasks were 
performed, such as their blood pressure being taken. In these circumstances, despite no acute 
intervention being required, the hospital environment was important to patients, suggesting 
that even with greater availability of community healthcare services, these visits might still have 
occurred.  
Patients’ Prior Emergency Department Attendance 
Research has shown that patients’ prior use and experiences of healthcare services influences 
their future use (130-132). For example, Greenlick et al. found the most powerful discriminator 
of whether a man would respond to an invitation for cardiovascular screening was whether he 
had received any medical care in the preceding two years (130). Prior to this study, the 
relationship between cancer patients’ previous ED use and ED attendance towards the end-of-
life had not been explored. The retrospective cohort study found a dose-response pattern 
between patients’ prior number of ED visits and their attendance in the last month of life. 
Compared to patients with no ED visits in the 11 months prior to the last month of life, the odds 
of multiple ED visits during the last 30 days increased with each additional visit, p for trend 
<0.001 (Figure 7.3). These novel findings were supported by those of the qualitative interview 
study. Patients described defaulting to services they had prior experience of when faced with an 
acute/urgent situation. They also described challenges in accessing community healthcare 
services and feeling reassured by the hospital environment which allowed them to abdicate 




Figure 7.3: Relationship between cancer patients’ prior ED attendance and odds of multiple ED visits in 
the last 30 days of life  
(Publication 3)  
Summary of Integrated Environmental Findings 
The integrated findings support an association between environmental factors (low SES; fewer 
community healthcare services; no palliative care) and an increased odds of multiple ED visits in 
the last month of life. A dose-response pattern between patients’ prior number of ED visits and 
their attendance in the last month of life was also found. The relationship between SES and end-
of-life ED visits is hypothesised to be due to different health beliefs and behaviours across social 
class. For community and palliative care services, and prior ED visits, issues of access, safety, and 




7.3 Conceptual Model 
The integrated findings of this study have been used to develop a conceptual model. In this 
model the main factors and concepts – and the presumed relationships between them – 
contributing to the phenomenon of cancer patients’ end-of-life ED use are presented.  
 




7.4 Strengths and Limitations 
The strengths and limitations of this mixed methods study are detailed below, including the 
decision to employ mixed methods, the use of existing models of health-seeking behaviour and 
the choice of ED attendance as an indicator of the quality of end-of-life cancer care. The 
strengths and limitations specific to each study component are presented in their corresponding 
publications. These discussions are not repeated below apart from those regarding the use of 
routine data for which further reflection is warranted.  
7.4.1 Use of Mixed Methods 
One of the key strengths of this study was the decision to employ mixed methods. The 
underlying logic for mixing quantitative and qualitative data is that individually, neither method 
would be sufficient for capturing the detail and complexity of the study subject (69). By utilising 
the strengths of both quantitative and qualitative approaches, mixed methods research can be 
particularly beneficial when investigating complex behavioural and/or clinical scenarios (73, 74, 
133). The phenomenon of cancer patients’ end-of-life ED use is complex, dynamic and multi-
faceted. A mixed methods study was therefore ideal as it allowed a more in-depth and complete 
analysis to be conducted. Furthermore, prior to this study, an integrated summary of cancer 
patients’ end-of-life ED use, based on quantitative and qualitative data, was lacking.  
In summary, by employing mixed methods, this study was able to: 
1) Determine factors associated with cancer patients’ end-of-life ED use for the first time 
within a UK population (quantitative component). 
2) Add to the limited research exploring advanced cancer patient’s health-seeking 
behaviour (qualitative component). 
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3) Develop the first conceptual model of the factors and concepts – and the presumed 
relationships between them – contributing to the phenomenon of cancer patients’ end-
of-life ED use (quantitative and qualitative components). 
Although the decision to use mixed methods was considered a key overall strength, it also 
presented challenges. Knowledge of both quantitative and qualitative methodologies was 
required, as well as additional time to plan and conduct each component and then integrate the 
findings. With a background in clinical medicine I have experience of prioritising activities and 
managing multiple work strands, and whilst I found this experience valuable, my skills were not 
directly transferable to the research setting. In clinical medicine ‘tasks’ or ‘jobs’ are mostly 
completed in minutes to hours, for example admitting a patient to hospital. There is also 
guidance on prioritising activities and an expectation to handover outstanding tasks at the end 
of each shift. In the research setting, tasks would typically take me weeks or months to 
complete. Keeping on track of the study’s overall progress was often difficult, and on occasions 
I was unsure when a task had been completed and lacked confidence to move to the next stage 
of the study or acknowledge that a change in direction was required. During these times I was 
guided by my supervisors. I learned the importance of flexibility and pragmatism when 
conducting clinical research, experiencing first-hand that despite best intentions, research 
studies don’t always go as planned. This was particularly evident when delays accessing data 
from NHS Digital required me to explore alternative quantitative datasets. Initially I found this 
difficult and struggled to see past the limitations. However, as the process continued I came to 
appreciate that all datasets have strengths and limitations, and completing a study with an 
acknowledgement of these limitations is much better than striving, and then failing, to deliver 
the perfect study.  
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7.4.2 Models of Health-Seeking Behaviour 
A further strength of this study was its use of extant models of health-seeking behaviour, 
including Andersen and Newman’s Behavioural Model of Health Services Use, Young’s Choice-
Making Model, and Padgett and Brodsky’s modified version of the Behaviour Model of Health 
Services Use (55, 57, 59). These models highlighted important concepts worthy of investigation, 
guided the quantitative and qualitative integration process, and also provided a framework for 
the conceptual model developed. 
The use of existing models also had limitations. None of the models identified were developed, 
or had been applied, to patients with advanced cancer and/or at the end-of-life. This meant that 
concepts specific to the health-seeking behaviour of this population would be missing from the 
models. Furthermore, some of the underlying health and behavioural theories that the models 
were built on do not necessarily translate to those at the end-of-life. The ‘sick role’, a term 
coined by Talcott Parsons in 1951, is one of the earliest and most recognised health and illness 
theories (134). One of the underlying assumptions of the sick role is that ‘health is a good thing, 
illness a bad thing and thereby the doctor and patient must want and strive towards regaining 
health’ (134). However, for those approaching the end-of-life, these assumptions don’t 
necessarily hold true; instead the focus of care typically shifts away from life-extending 
treatments and towards maximising the quality of life remaining. These limitations were 
acknowledged from the outset and highlighted the importance of using the information gained 
from the models as a guide, rather than attempting to fit the findings of this study to one of the 
existing models/theories. To aid this process, models specific to palliative and end-of-life care, 




7.4.3 Use of Routinely Collected Health Data 
The quantitative component of this study used routinely collected mortality data from the ONS 
linked to routinely collected ED data from HES (72). This linkage created a bespoke dataset with 
a number of strengths. The use of routine data negated the need for primary data collection, 
therefore saving both time and money. The dataset also contained valuable population-level 
data for a vulnerable group of patients – those in the final weeks of life – who are often excluded 
from clinical trials due to recruitment challenges and/or high levels of attrition (136).  
Limitations of the dataset mostly related to issues of data quality. Many of the dataset’s clinical 
variables (supplied by HES) were unsuitable for analysis due to high levels of missing and/or 
invalid data. The systematic literature review conducted as background to this study, identified 
clinical characteristics as an important concept requiring further investigation. It was therefore 
particularly disappointing that data quality issues meant it was not possible to explore the 
relationship between cancer patients’ end-of-life ED use and a number of clinical variables, such 
as symptoms. I have since reflected on whether this limitation could have been anticipated 
and/or attenuated. All of the HES ED variables are described in a data dictionary which was 
reviewed at the time of the NHS Digital application (137). Figure 7.5 provides an example of the 
type of information contained in the dictionary for each variable.  
The data dictionary (137) did not provide any information about data quality apart from the 
following statement at the beginning of the document:  
There are known weaknesses in the data, but rather than withhold this already useful 
dataset we have released it as 'experimental' and are seeking feedback from data suppliers 
and users to help us bring about rapid improvements and developments needed to support 





Figure 7.5: Example of information provided about Hospital Episode Statistics variables 
Whilst I expected that the dataset would contain variables with limited and/or unusable data, I 
did not consider which variables would most likely be affected and how this might impact the 
overall study. Compared to socio-demographic factors, empirical data describing the 
relationship between patients’ clinical characteristics and their end-of-life ED use is limited. This 
is likely to reflect issues of data quality more broadly and highlights some of the current 
challenges of using routinely collected healthcare data for research. Addressing the validity of 
clinically coded variables is an important next step towards maximising the value of such 
resources. 
7.4.4 Emergency Department Use as a Performance Indicator 
Fundamental to this study was the decision to explore ED use as a marker of the quality of end-
of-life cancer care. This decision was based on several factors. Firstly, the proportion of patients 
with multiple ED visits in the last month of life is a validated indicator of overly aggressive end-
of-life cancer care (26), and consistent high-quality evidence exists for a link between overly 
aggressive end-of-life cancer care and poor patient and caregiver outcomes (61, 63, 138). 
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Secondly, routinely collected population data is available for all NHS ED visits in England, but 
prior to this study, had not been used to examine the quality of end-of-life cancer care. Thirdly, 
ED use continues to receive intense social and political attention. Across developed countries, 
EDs are facing considerable pressure to evolve and become more efficient, whilst also 
experiencing ever increasing demand and expectations of care. Empirical data that can help 
understand patients’ ED use is essential to support service development and healthcare policy. 
Using ED attendance as a marker of end-of-life care quality has limitations. It is important to 
acknowledge that the proportion of patients with multiple ED visits in the last month of life is an 
indicator of the quality of end-of-life cancer care at a population level, not an individual level. In 
many situations the ED is the most appropriate setting for urgent care needs to be investigated 
and/or managed, and in such circumstances ED attendance should be encouraged. By promoting 
end-of-life ED use as a performance indicator there is a risk that all end-of-life ED visits will be 
interpreted as representing poor quality care. This has been a criticism of previously used 
performance measures, for example the proportion of people dying in their own home (139).  
Evaluating the quality of end-of-life care is challenging and examining isolated performance 
measures, such as ED use, may not accurately represent the overall picture. For example, Teno 
et al. found a significant increase in the proportion of home deaths for Medicare beneficiaries 
in the USA between 2000, 2005 and 2009. In isolation this trend suggested that end-of-life care 
was becoming less aggressive over time. However, further analysis found that during the same 
time period there were significant increases in the number of end-of-life healthcare transitions 
and admissions to intensive care (test of trend p<0.001) (140). Whilst the proportion of cancer 
patients with multiple ED visits in the last month of life is a recognised indicator of end-of-life 
care quality, it is only one indicator, and as such, it should be interpreted and explored alongside 
other markers of end-of-life care quality, such as the proportion of patients receiving 
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chemotherapy in the last 14 days of life. Unfortunately, exploration of these additional measures 
was beyond the scope of this thesis, however future research exploring these relationships is 
planned.  
Lastly, for future populations, the proportion of patients with multiple ED visits in the last month 
of life may no longer be a valid indicator of overly aggressive end-of-life cancer care. With the 
effects of population growth and ageing, the future average cancer patient will be older and 
more likely to have one or more co-morbidities. Oncology treatment and care is also developing 
rapidly, with treatments becoming increasingly available to those with advanced disease and in 
the later stages of illness. It can be hypothesised that older patients with more co-morbidities 
who continue to receive active oncological treatment will have greater acute care needs and an 
increased demand for hospital care towards the end-of-life. In this context, re-exploring the 
validity of ED use as an indicator of overly aggressive end-of-life care would be important. 
7.5 Implications for Clinical Practice, Healthcare Policy and Future Research 
7.5.1 Implications for Clinical Practice 
Relevant to healthcare professionals and clinical practice, this study has highlighted the 
complexity of individuals’ decision-making and the importance of patients’ symptom perception 
and interpretation. Clinical medicine requires healthcare professionals to regularly review 
patients’ symptoms or take what is known as a ‘symptom history’. During this process, a 
healthcare professional will ask a patient a series of questions pertinent to their symptom(s) in 
order to generate a list of possible diagnoses. Further investigations and/or treatment can then 
be organised accordingly. During the qualitative interview study patients were asked to describe 
and explain the symptom(s) that led to them seeking ED care. Whilst my training as a palliative 
care physician has afforded me considerable opportunities to develop my history taking and 
communication skills, conducting qualitative interviews made me listen to patients differently. 
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By completely emerging myself in a patient’s narrative, without trying to seek a diagnosis or 
develop a management plan, I more fully appreciated the meaning that certain symptoms had 
to patients’ and their caregivers. This in turn helped me understand patients’ thought processes 
and their resulting behaviours. Concepts such as safety would not have been identified without 
this qualitative approach and has led to me reflecting on the meaning of this to clinical practice. 
This study has highlighted the value of using a different approach to history taking. The 
importance of listening and being able to adapt communication styles for different clinical 
situations and/or patient groups is evident. Future research exploring how different history 
taking approaches influence patients’ end-of-life care and their use of healthcare services would 
be valuable (141-144). 
7.5.2 Implications for Healthcare Policy and Future Research 
For managers and policy-makers, knowledge of high-risk patient characteristics can help with 
allocating resources and planning future services. This is especially important given the ageing 
population and anticipated rise in cases of cancer. This research determined that in England, 
between 01/04/2011 and 31/03/2012, 30.7% (n=38,049) of cancer decedents attended the ED 
once during their last month of life and 5.1% (n=6,325) attended multiple times. With population 
growth and ageing these figures can be anticipated to increase to n=46,454 and n=7,717 
respectively by 2030, highlighting the extent and urgency with which healthcare services need 
to evolve.  
During the earlier stages of this study I proposed using the research findings to develop an early 
warning system or screening tool. Early warning systems are a major component of disaster risk 
reduction strategy, having been developed from the understanding that ‘although disasters 
often appear to happen suddenly with little or no prior warning, in fact, most disasters incubate 
over long gestation periods during which warning events accumulate’ (p. 1071) (145). Their use 
 123 
 
extends from predicting and warning of natural disasters to the forecasting of impending 
financial crises (145). An effective early warning system involves the regular analysis of routine 
information that may be predictive of a future threat or hazard, with the aim of providing 
sufficient warning for preventative action to be taken. When developed and implemented well, 
early warning systems have been shown to save lives. For example, The Nationwide Operational 
Assessment of Hazards (NOAH) Project is an early warning system that was initiated by the 
Philippines government to warn of intense weather conditions, and in 2012, it enabled more 
than 167,000 people to be evacuated to safety prior to Typhoon Bopha (146). Within the 
healthcare setting, early warning systems have been successfully integrated into clinical 
practice, so much so that in 2007 NICE recommended the use of physiological track and trigger 
systems for all adult hospital in-patients (147).  
The use of early warning systems across other healthcare disciplines led to me considering their 
role in palliative and end-of-life care. The quantitative findings of this study could be used to 
develop an early warning system capable of identifying cancer patients with an increased risk of 
multiple ED visits towards the end-of-life. This could be used to improve patient outcomes 
through various mechanisms, such as triggering an earlier referral to palliative care services 
(148-151). Future research testing and evaluating such an intervention is planned.  
This research has also highlighted the importance of understanding the context and complexity 
of patients’ healthcare utilisation. The pace of change in healthcare and pressure on services to 
evolve immediately present many challenges, including for researchers. Many randomised 
controlled trials and quasi experimental studies have failed to make an impact beyond the study 
setting and it may be that pressure to assess the effectiveness of interventions has led to large-
scale quantitative analyses being conducted before an adequate understanding of the research 
problem has been compiled. Mixed methods research may reduce some of these issues. 
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Incorporating a qualitative component to studies that would have traditionally been solely 
quantitative, could help researchers understand and interpret their quantitative research, as 
well as support the implementation of the research findings to other settings.  
7.6 Conclusions 
Socio-demographic (younger age; male sex; Asian or Black ethnicity; low socio-economic status), 
clinical (high co-morbidity score; diagnosis of lung or head and neck cancer) and environmental 
(fewer community healthcare services; lack of palliative care; high previous ED use) factors are 
associated with an increased risk of multiple ED visits towards the end-of-life by people with 
cancer. Issues influencing advanced cancer patients’ and their caregivers’ decisions to seek ED 
care are complementary and propose underlying mechanisms of action for the quantitative 
associations found. Difficulties accessing community healthcare services and feelings of safety 
and familiarity with the hospital setting appear to support the quantitative environmental 
factors, whilst disease-related anxiety may explain some of the variation found in ED use across 
different socio-demographic groups. The findings provide evidence for the development of 
future interventions to address these aspects. These may include: 1. Early warning systems or 
screening tools based on the quantitative factors, leading to earlier engagement with relevant 
services such as palliative care; and, 2. Support for healthcare professionals in exploring patients’ 
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